As shown for other [68Ga]Ga‐DOTA peptides, lutetium‐177 labelling would potentially serve as a therapeutic but also for surgical debulking in primary tumours where KISS1R has a tumour suppression effect. This evidence concerns the gene KISS1R and neoplasm.